A recently published study set out to explore whether there was a direct association between high potency cannabis (characterized by a high concentration of THC, the primary psychoactive compound) and an increased risk of anxiety, depression, psychosis-like symptoms, and cannabis dependence. The study was cross-sectional, involving 410 participants who provided cannabis samples for THC concentration analysis and self-reported their cannabis potency preference.
Legal on paper, restricted in practice. Inside Germany’s cannabis system, where cultivation is allowed but…
The idea may sound strange: a tobacco plant producing compounds like psilocybin or DMT. Sounds…
The term “addiction” gets thrown around quite freely in everyday language—this is nothing new. Who…
Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov…
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products…
Here we are in 2026, and a conflict that was supposed to wrap up in…